Related Experiment Video
Updated: Aug 20, 2026

Analysis of Nephron Composition and Function in the Adult Zebrafish Kidney
Published on: August 9, 2014
[Some important news in clinical nephrology in years 2003-2004]
1Klinika nefrologie 1. lékarské fakulty UK a VFN, Praha.
Insights
A new classification helps manage chronic renal disease (CRD) risks. Treatments like statins and specific drug combinations can reduce cardiovascular issues and slow kidney disease progression.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Context:
- Chronic renal diseases (CRD) are increasingly common, particularly with age.
- Cardiovascular complications are the primary cause of morbidity and mortality in CRD patients.
- CRD patients face unique risks like anemia and hyperphosphatemia, alongside traditional cardiovascular risk factors.
Purpose:
- To introduce a novel classification system for chronic renal diseases.
- To stratify the risk of complications associated with chronic renal insufficiency and cardiovascular diseases.
- To highlight evidence-based treatment strategies for managing CRD and its comorbidities.
Summary:
- The new classification aids in stratifying risks for chronic renal insufficiency and associated cardiovascular diseases.
- Cardiovascular complications are the leading cause of death in CRD patients, exacerbated by dyslipidemia.
- Treatments including statins, ACE inhibitors combined with angiotensin antagonists, and emerging monoclonal antibodies show promise in managing CRD progression and cardiovascular risk.
Impact:
- Improved risk stratification for better patient management and outcomes in chronic renal disease.
- Potential reduction in cardiovascular morbidity and mortality among patients with chronic renal insufficiency.
- Slowing the progression of chronic renal insufficiency and managing specific renal complications through targeted therapies.
Abstract:
A new classification of chronic renal diseases enables to stratify risk of complications of chronic renal insufficiency and cardiovascular diseases. Chronic renal diseases are not rare, their incidence increases with age. Main causes of morbidity and mortality of patients with chronic renal diseases are cardiovascular complications. Besides typical risk factors, patients with chronic renal disease are at risk of specific renal diseases (such as anaemia or hyperphosphatemia). A cardiovascular risk of renal patients also increases dislipidemia. Statin treatment is able to decrease not only cardiovascular morbidity and mortality but also to slow down progression of chronic renal insufficiency. Nondiabetic nephropathies progression also significantly decreases a combination of an angiotensin converting enzyme and an angiotensin antagonist. Also in patients with chronic glomerulonephritides treatment is currently indicated according to evidence based medicine. Some monoclonal antibodies (such as infliximab or rituximab) seem to be promising among new drugs.
More Related Videos
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Renal Drug Clearance: Overview
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Acute Kidney Injury III: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Nephrotic Syndrome III : Nursing Management
